SEC Form 4 · accession 0000899243-16-016307
MARVELL TECHNOLOGY GROUP LTD · MRVL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zining Wu
Officer — CTO
Period of report
Mar 16, 2016
Accepted (ET)
Mar 18, 2016 · 8:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001058057
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | holding | — | — | — | 93,793 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Award (Right to Acquire)F3,F2 | — | Mar 16, 2016 | A | 33,616 | A | — | Apr 1, 2016 | Common Shares | 33,616 | 33,616 | D |
Explanation of responses
- F1Includes 1,641 shares acquired under the Marvell 2000 Employee Stock Purchase Plan on June 5, 2015, in an exempt transaction under Rule 16b-3(c) of the Securities Exchange Act of 1934.
- F2Each performance award represents a contingent right to receive one Marvell Technology Group Ltd. ("Marvell") common share.
- F3On March 16, 2016, the Executive Compensation Committee of the Board of Directors of Marvell (the "Compensation Committee") determined that the performance criteria related to 33,616 common shares subject to a performance award granted to Dr. Zining Wu on April 30, 2015 were met, and the common shares issuable in respect of these performance awards will vest on April 1, 2016 subject to Dr. Wu's continuous status as a service provider through such date.